© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
James R. Rigas, MD | Authors
Articles
Single-Agent Docetaxel in Previously Untreated Non-Small-Cell Lung Cancer
July 01, 1997
Four phase II trials have beenconducted to evaluate the efficacy and tolerability of single-agent docetaxel